Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 2

Conditions

Multiple Endocrine Neoplasia Type 1 96Pituitary Neoplasms 57Neuroendocrine Tumors 50Thyroid Cancer, Papillary 42Thyroid Neoplasms 16Obesity 15Pheochromocytoma 14Overweight 11Adrenal Gland Neoplasms 10Weight Loss 9Paraganglioma 9Carcinoma, Neuroendocrine 9Pancreatic Neoplasms 8Prostatic Neoplasms 7Motor Activity 7Insulinoma 7Gastrointestinal Neoplasms 7Brain Neoplasms 7Adrenocortical Adenoma 7Acquired Immunodeficiency Syndrome 7Neoplasm Metastasis 6Hyperaldosteronism 6Carcinoma, Medullary 6Stomach Neoplasms 5Osteoporosis 5Neoplasms 5Meningioma 5Liver Neoplasms 5Insulin Resistance 5HIV Infections 5

Interventions

Saline Solution 1Hydrocortisone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Adrenal Insufficiency × Endocrine × Clear all
NCT04621565 2020-11-09

Hydrocortisone Use During Peri-operation for Pituitary Adenomas

Peking Union Medical College Hospital

Phase NA Unknown
436 enrolled
Endocrine

Adrenal Insufficiency, Pituitary Neoplasms

NCT03083834 2019-01-18

Salivary Free Cortisol Response to Cosyntropin Stimulation Test in Mitotane Treated Patients

Bnai Zion Medical Center

Phase NA Unknown
50 enrolled
Endocrine

Adrenal Insufficiency, Adrenal Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡